Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model

Plexiform neurofibromas (PNF), one of the major features of neurofibromatosis type 1 (NF1), are characterized by complex cellular composition and mostly slow but variable growth patterns. In this study, we examined the effect of imatinib mesylate, a receptor tyrosine kinase inhibitor, on PNF-derived...

Full description

Saved in:
Bibliographic Details
Other Authors: Demestre, Maria (Other) , Herzberg, Jan (Other) , Holtkamp, Nikola (Other) , Hagel, Christian (Other) , Reuss, David (Other) , Friedrich, Reinhard E. (Other) , Kluwe, Lan (Other) , Deimling, Andreas von (Other) , Mautner, Victor Felix (Other) , Kurtz, Andreas (Other)
Format: Article (Journal)
Language:English
Published: 2010
In: Journal of neuro-oncology
Year: 2010, Volume: 98, Issue: 1, Pages: 11-20
ISSN:0167-594X
Online Access: Get full text
Author Notes:Maria Demestre, Jan Herzberg, Nikola Holtkamp, Christian Hagel, David Reuss, Reinhard E. Friedrich, Lan Kluwe, Andreas von Deimling, Victor-F. Mautner, Andreas Kurtz

MARC

LEADER 00000caa a22000002c 4500
001 657900818
003 DE-627
005 20240311131755.0
007 tu
008 110512s2010 xx ||||| 00| ||eng c
035 |a (DE-627)657900818 
035 |a (DE-576)9657900816 
035 |a (DE-599)GBV657900818 
035 |a (OCoLC)1425877048 
035 |a (OLC)1842943103 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model  |c Maria Demestre, Jan Herzberg, Nikola Holtkamp, Christian Hagel, David Reuss, Reinhard E. Friedrich, Lan Kluwe, Andreas von Deimling, Victor-F. Mautner, Andreas Kurtz 
264 1 |c 2010 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
520 |a Plexiform neurofibromas (PNF), one of the major features of neurofibromatosis type 1 (NF1), are characterized by complex cellular composition and mostly slow but variable growth patterns. In this study, we examined the effect of imatinib mesylate, a receptor tyrosine kinase inhibitor, on PNF-derived Schwann cells and PNF tumour growth in vitro and in vivo. In vitro, PNF-derived primary Schwann cells express platelet-derived growth factors receptors (PDGFR) alpha and beta, both targets of imatinib, and cell viability was reduced by imatinib mesylate, with 50% inhibition concentration (IC(50)) of 10 microM. For in vivo studies, PNF tumour fragments xenografted onto the sciatic nerve of athymic nude mice were first characterized. The tumours persisted for at least 63 days and maintained typical characteristics of PNFs such as complex cellular composition, low proliferation rate and angiogenesis. A transient enlargement of the graft size was due to inflammation by host cells. Treatment with imatinib mesylate at a daily dose of 75 mg/kg for 4 weeks reduced the graft size by an average of 80% (n = 8), significantly different from the original sizes within the group and from sizes of the grafts in 11 untreated mice in the control group (P < 0.001). We demonstrated that grafting human PNF tumour fragments into nude mice provides an adequate in vivo model for drug testing. Our results provide in vivo and in vitro evidence for efficacy of imatinib mesylate for PNF. 
700 1 |a Demestre, Maria  |0 (DE-588)1315156164  |0 (DE-627)1877360791  |4 oth 
700 1 |a Herzberg, Jan  |d 1983-  |0 (DE-588)1044389869  |0 (DE-627)771948727  |0 (DE-576)39704240X  |4 oth 
700 1 |a Holtkamp, Nikola  |d 1970-  |0 (DE-588)122140451  |0 (DE-627)081760574  |0 (DE-576)293113114  |4 oth 
700 1 |a Hagel, Christian  |0 (DE-588)1027617506  |0 (DE-627)729488497  |0 (DE-576)373465750  |4 oth 
700 1 |a Reuss, David  |d 1976-  |0 (DE-588)143839837  |0 (DE-627)655107894  |0 (DE-576)339294337  |4 oth 
700 1 |a Friedrich, Reinhard E.  |0 (DE-588)121482286  |0 (DE-627)522672418  |0 (DE-576)292733038  |4 oth 
700 1 |a Kluwe, Lan  |0 (DE-588)1028383398  |0 (DE-627)730641775  |0 (DE-576)375922253  |4 oth 
700 1 |a Deimling, Andreas von  |d 1959-  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 oth 
700 1 |a Mautner, Victor Felix  |0 (DE-588)102837545X  |0 (DE-627)730625141  |0 (DE-576)375911421  |4 oth 
700 1 |a Kurtz, Andreas  |4 oth 
773 0 8 |i in  |t Journal of neuro-oncology  |d Dordrecht : Springer, 1983  |g 98(2010), 1 vom: Mai, Seite 11-20  |w (DE-627)167915800  |w (DE-600)604875-4  |w (DE-576)015902951  |x 0167-594X  |7 nnas  |a Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model 
773 1 8 |g volume:98  |g year:2010  |g number:1  |g month:05  |g pages:11-20  |g extent:9  |a Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model 
776 0 8 |i Erscheint auch als  |n Online-Ausgabe  |a Demestre, Maria  |t Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model  |d 2010  |w (DE-627)1877359076 
951 |a AR 
992 |a 20240105 
993 |a Article 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 143839837  |a Reuss, David  |m 143839837:Reuss, David  |d 910000  |d 912000  |e 910000PR143839837  |e 912000PR143839837  |k 0/910000/  |k 1/910000/912000/  |p 5 
999 |a KXP-PPN657900818  |e 444960752X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"oth","family":"Demestre","display":"Demestre, Maria","given":"Maria"},{"role":"oth","family":"Herzberg","display":"Herzberg, Jan","given":"Jan"},{"role":"oth","display":"Holtkamp, Nikola","given":"Nikola","family":"Holtkamp"},{"role":"oth","family":"Hagel","given":"Christian","display":"Hagel, Christian"},{"given":"David","display":"Reuss, David","family":"Reuss","role":"oth"},{"role":"oth","family":"Friedrich","display":"Friedrich, Reinhard E.","given":"Reinhard E."},{"role":"oth","family":"Kluwe","display":"Kluwe, Lan","given":"Lan"},{"family":"Deimling","given":"Andreas von","display":"Deimling, Andreas von","role":"oth"},{"role":"oth","given":"Victor Felix","display":"Mautner, Victor Felix","family":"Mautner"},{"given":"Andreas","display":"Kurtz, Andreas","family":"Kurtz","role":"oth"}],"relHost":[{"language":["eng"],"disp":"Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft modelJournal of neuro-oncology","title":[{"title":"Journal of neuro-oncology","title_sort":"Journal of neuro-oncology"}],"type":{"bibl":"periodical"},"part":{"pages":"11-20","year":"2010","issue":"1","extent":"9","text":"98(2010), 1 vom: Mai, Seite 11-20","volume":"98"},"note":["Laut Verlagsankündigung mit 2017 als gedruckte Ausgabe eingestellt, 136.2018,1-2 versehentlich noch gedruckt","2018 fortgesetzt als Online-Ausgabe ausgeliefert"],"origin":[{"publisherPlace":"Dordrecht ; Boston, Mass. [u.a.] ; Dordrecht [u.a.]","dateIssuedDisp":"1983-2018","publisher":"Springer ; Nijhoff ; Kluwer Academic Publishers","dateIssuedKey":"1983"}],"pubHistory":["1.1983 - 136.2018,2"],"id":{"issn":["0167-594X"],"eki":["167915800"],"zdb":["604875-4"]},"recId":"167915800"}],"physDesc":[{"extent":"9 S."}],"type":{"bibl":"article-journal"},"title":[{"title":"Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model","title_sort":"Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model"}],"language":["eng"],"recId":"657900818","id":{"eki":["657900818"]},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"name":{"displayForm":["Maria Demestre, Jan Herzberg, Nikola Holtkamp, Christian Hagel, David Reuss, Reinhard E. Friedrich, Lan Kluwe, Andreas von Deimling, Victor-F. Mautner, Andreas Kurtz"]}} 
SRT |a IMATINIBME2010